FDA

/Tag: FDA

Breaking Down Bisphosphonates

2019-04-01T18:56:26-05:00April 1st, 2019|

    No hoof, no horse, right? It’s a no-brainer statement that all horse owners repeat to themselves relentlessly. Aside from the well-known laminitis and founder, another notorious hoof ailment called navicular syndrome is an issue that attacks the bone structure at the back of the hoof. This is commonly [...]

Bisphosphonate Concerns

2019-03-27T17:59:14-05:00March 27th, 2019|

  Amid Bone Strength Concerns, Sales Companies Announce Bisphosphonate Policies for Young Horses by Nicolle Neulist   In light of rising concerns about the effects of off-label use of a group of drugs called bisphosphonates on bone development of young Thoroughbreds, leading sales companies Keeneland Association, Fasig-Tipton Company, Inc., and [...]